Geriatric multimorbidity – one of the key problem of contemporary medicine

Czech version

Authors: Pavel Weber; Dana Prudius; Hana Meluzínová
Authors‘ workplace: Klinika interní, geriatrie a praktického lékařství LF MU a FN Brno, pracoviště Bohunice, přednostka prof. MUDr. Hana Matějovská Kubešová, CSc.
Published in: Vnitř Lék 2015; 61(12): 1042-1048
Category: Reviews

Overview

In the elderly population there are common permanent decrease of functional capacity, gradual emergence of various diseases leading to the wider multimorbidity and increased problems in the social sphere, which can develop frailty and social dependency. The paper analyzes the complex issue of geriatric multimorbidity and emphasizes its pitfalls, the need of an interdisciplinary approach and thinking of doctors, including the risks of modern pharmacotherapy. The aim of geriatric medicine is to optimize residual functions despite the decline in total functional capacity with increasing multimorbidity. The authors want to direct the attention of the professional community to the permanently growing numbers of the elderly and to emphasize the need of awareness of the problem so that they could understand and cope with this absolutely new reality.

Keywords:
ageing of population – atomization of medicine – geriatrization of medicine – holistic approach – multimorbidity

Sources

1. Zdravotnická ročenka ČR 2013. Praha: ÚZIS ČR: 2014. SBN: 978–80–7472–135–9. Dostupné z WWW: http://www.uzis.cz/publikace/zdravotnicka-rocenka-ceske-republiky-2013.

2. Český statistický úřad. Dostupné z WWW: https://www.czso.cz/csu/czso/souborne-publikace; www.users.rcn.com/jkimball.ma.ultranet/biologypages/W/welcome/hml. [Citováno 2015–06–07].

3. Halter J, Ouslander J, Tinetti M et al (eds). Hazzard’s Geriatric Medicine and Gerontology. 6th ed. (Principles of Geriatric Medicine & Gerontology). McGraw-Hill Professional: New York 2009.

4. Keeler E, Guralnik JM, Tian H et al. The impact of functional status on life expectancy in older persons. J Gerontol A BiolSci Med 2010; 65(7): 727–733.

5. Jacobs JM, Maaravi Y, Cohen A et al. Changing profile of health and function from age 70 to 85 years. Gerontology 2012; 58(4): 313–321.

6. Morley JE, Vellas B, van Kan GA et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14(6): 392–397.

7. Fried LP, Ferrucci L, Darer J et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59(3): 255–263.

8. Rockwood K, Song X, Mac Knight C et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173(5): 489–495.

9. Hegyi L, Krajčík Š et al. Geriatria. Herba: Bratislava 2010. ISBN 978–80–89171–73–6.

10. Topinková E. Geriatrie pro praxi. Galén: Praha 2005. ISBN 80–7262–365–6.

11. Kalvach Z, Zadák Z, Jirák R et al. Geriatrické syndromy a geriatrický pacient. Galén: Praha 2008. ISBN 978–80–247–2490–4.

12. Valderas JM, Starfield B, Sibbald B et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009; 7(4): 357–363.

13. Boyd CM, Fortin M. Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? Public Health Reviews 2010; 32(2): 451–474. Dostupné z WWW: http://www.publichealthreviews.eu/upload/pdf_files/8/PHR_32_2_Boyd.pdf.

14. Marengoni A, Angleman S, Melis R et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 2011; 108(4): 430–439.

15. Menotti A, Mulder I, Nissinen A et al. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol 2001; 54(7): 680–686.

16. Fortin M, Hudon C, Haggerty J et al. Prevalence estimates of multimorbidity: a comparative study of two sources. BMC Health Serv Res 2010; 10: 111. Dostupné z WWW: http://www.biomedcentral.com/1472–6963/10/111.

17. Schäfer I, Hansen H, Schön G et al. The German MultiCare-study: Patterns of multimorbidity in primary health care – protocol of a prospective cohort study. BMC Health Serv Res 2009; 9: 145. Dostupné z WWW: http://www.biomedcentral.com/1472–6963/9/145.

18. Schäfer I, von Leitner EC, Schön G et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One 2010; 58(12): e15941. Dostupné z DOI: <http://doi: 10.1371/journal.pone.0015941>.

19. Heiss HW (ed). Altersmedizin aktuell. Interdisziplinäre geriatrische Versorgung, 32. Ergänzungslieferung. Ecomed MEDIZIN: Heidelberg, München, Landsberg, Frechen, Hamburg 2014. ISBN 978–3-609–10370–9.

20. Berková M, Topinková E, Mádlová P et al. Krátká baterie pro testování fyzické zdatnosti seniorů – pilotní studie a validizace testu u starších osob v České republice Vnitř Lék 2013; 59(4): 256–263.

21. Weber P, Ambrošová P, Weberová D et al. Geriatrické syndromy a syndrom frailty zlatý grál geriatrické medicíny. Vnitř Lék 2011; 57(11): E2010_18. Dostupné z WWW: http://www.vnitrnilekarstvi.eu/vnitrni-lekarstvi-clanek/geriatricke-syndromy-a-syndrom-frailty-zlaty-gral-geriatricke-mediciny-36460.

22. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987: 40(5); 373–383.

23. Matějovská Kubešová H. Geriatrický nemocný v onkologii. Vnitř Lék 2014; 60(Suppl 2): 46–53.

24. Boyd CM, Darer J, Boult C et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294(6): 716–724.

25. Jadad AR, To MJ, Emara M et al. Consideration of multiple chronic diseases in randomized controlled trials. JAMA 2011; 306(24): 2670–2672.

26. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc 2012; 60(10): E1-E25.

27. Steinman MA, Handler SM, Gurwitz JH et al. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 2011; 59(8): 1513–1520.

28. Zulman DM, Sussman JB, Chen X et al. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 2011; 26(7): 783–790.

29. Boult C, Wieland GD Comprehensive primary care for older patients with multiple chronic conditions: “Nobody rushes you through”. JAMA 2010; 304(17): 1936–1943.

30. Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008; 37(6): 673–679.

31. Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. American Geriatrics Society 2012 Beers Criteria Update. J Am Geriatr Soc 2012; 60(4): 616–631.

32. Scott IA, Gray LC, Martin JH et al. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med 2012; 125(6): 529–537.

33. Emmett KR. Nonspecific and atypical presentation of disease in the older patient. Geriatrics 1998; 53(2): 50–52, 58–60.

34. Wrobel N. Demografieinduzierte Multi-Morbidität – Komplexleistung Im DRG-Vergütungssystem. Recht Und Politik Im Gesundheitswesen 2008; 14(1): 7–10.

35. Weber P. Nová intervenční gerontologie v epoše geriatrizace medicíny. Vnitř Lék. 2001; 47(2): 106–110.